Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-19-031007

Options or other derivatives

  • Director acquired 6,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HILL STEPHEN A Director 2019-06-13 Grant or award · Stock option (right to buy) +6,500 6,500 D
Loading xslF345X03/tv523608_4.xml…